董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Roberto Simon | 男 | Independent Director | 51 | 0.40万美元 | 未持股 | 2025-03-27 |
| Justin Schreiber | 男 | Chief Executive Officer and Chairman of the Board | 44 | 925.50万美元 | 未持股 | 2025-03-27 |
| John R. Strawn, Jr. | 男 | Independent Director | 65 | 未披露 | 未持股 | 2025-03-27 |
| Joseph V. DiTrolio | 男 | Independent Director | 75 | 未披露 | 未持股 | 2025-03-27 |
| William J. Febbo | -- | Director | -- | 未披露 | 未持股 | 2025-03-27 |
| Calum MacRae | -- | Independent Director | -- | 未披露 | 未持股 | 2025-03-27 |
| Joan LaRovere | -- | Independent Director | -- | 未披露 | 未持股 | 2025-03-27 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Justin Schreiber | 男 | Chief Executive Officer and Chairman of the Board | 44 | 925.50万美元 | 未持股 | 2025-03-27 |
| Stefan Galluppi | 男 | Chief Innnovation Officer and Chief Marketing Officer | 39 | 919.50万美元 | 未持股 | 2025-03-27 |
| Marc Benathen | 男 | Chief Financial Officer | 46 | 未披露 | 未持股 | 2025-03-27 |
| Nicholas Alvarez | 男 | Chief Acquisition Officer | 34 | 163.90万美元 | 未持股 | 2025-03-27 |
| Eric Yecies | 男 | Chief Legal Officer and General Counsel | 48 | 179.56万美元 | 未持股 | 2025-03-27 |
| Shayna Webb Dray | 女 | Chief Operating Officer | 38 | 未披露 | 未持股 | 2025-03-27 |
| Maria Stan | -- | Controller and Chief Accounting Officer | -- | 未披露 | 未持股 | 2025-03-27 |
| Jessica Friedeman | -- | Chief Marketing Officer | -- | 未披露 | 未持股 | 2025-03-27 |
| Shane Biffar | -- | Chief Compliance Officer and Deputy General Counsel | -- | 未披露 | 未持股 | 2025-03-27 |
| Dennis Wijnker | -- | Chief Technology Officer | -- | 未披露 | 未持股 | 2025-03-27 |
董事简历
中英对照 | 中文 | 英文- Roberto Simon
-
Roberto Simon，2014年9月起，担任本公司的执行副总裁、首席财务官。自2013年10月加入本公司之时起，他就担任全球财务高级副总裁；当时本公司收购了TCG，他是交易的一部分。加入本公司之前，他从2002年起，在TCG担任了愈益重要的多个职务，其中包括从2011年10月起担任首席财务官。2008年1月至2011年9月，他担任Colomer USA的美洲与非洲地区财务副总裁。
Roberto Simon was appointed as a member of the Board. Mr. Simon currently serves as Chief Financial Officer of WEX Inc. "WEX", a leading financial technology service provider. Mr. Simon joined WEX in February 2016. Previously, Mr. Simon served as the Executive Vice President and Chief Financial Officer of Revlon, Inc., a global cosmetics, personal and beauty care products company, from October 2014 until February 2016. Prior to that, he was the Revlon Senior Vice President, Global Finance from October 2013 to September 2014 and served as Revlon's Global Business Process Owner, SAP, from February 2014 until September 2014. Prior to joining Revlon as a result of Revlon's acquisition of The Colomer Group Participations, S.L. ("The Colomer Group"), a Spain-based salon and professional beauty business, Mr. Simon served in various senior finance positions of increasing responsibility at The Colomer Group since 2002 including most recently serving as The Colomer Group's Chief Financial Officer from October 2011 to October 2014. Prior to that, he served as The Colomer Group's Vice President of Finance for America and Africa from January 2008 until September 2011. - Roberto Simon，2014年9月起，担任本公司的执行副总裁、首席财务官。自2013年10月加入本公司之时起，他就担任全球财务高级副总裁；当时本公司收购了TCG，他是交易的一部分。加入本公司之前，他从2002年起，在TCG担任了愈益重要的多个职务，其中包括从2011年10月起担任首席财务官。2008年1月至2011年9月，他担任Colomer USA的美洲与非洲地区财务副总裁。
- Roberto Simon was appointed as a member of the Board. Mr. Simon currently serves as Chief Financial Officer of WEX Inc. "WEX", a leading financial technology service provider. Mr. Simon joined WEX in February 2016. Previously, Mr. Simon served as the Executive Vice President and Chief Financial Officer of Revlon, Inc., a global cosmetics, personal and beauty care products company, from October 2014 until February 2016. Prior to that, he was the Revlon Senior Vice President, Global Finance from October 2013 to September 2014 and served as Revlon's Global Business Process Owner, SAP, from February 2014 until September 2014. Prior to joining Revlon as a result of Revlon's acquisition of The Colomer Group Participations, S.L. ("The Colomer Group"), a Spain-based salon and professional beauty business, Mr. Simon served in various senior finance positions of increasing responsibility at The Colomer Group since 2002 including most recently serving as The Colomer Group's Chief Financial Officer from October 2011 to October 2014. Prior to that, he served as The Colomer Group's Vice President of Finance for America and Africa from January 2008 until September 2011.
- Justin Schreiber
-
Justin Schreiber是风险投资和资本市场咨询公司JLS Ventures的总裁兼创始人，该公司与企业家和新兴成长型公司合作，在技术，医疗保健和消费产品垂直领域开发颠覆性产品和技术。自2018年2月以来，Schreiber先生一直担任Conversion Labs Inc.的总裁，首席执行官兼董事，该公司是一家直接面向消费者的远程医疗公司。在创立JLS Ventures之前，Schreiber先生经营一家咨询业务，为小型上市公司提供投资者关系，咨询服务和融资解决方案。除了资本市场经验，Schreiber先生此前曾在一家全球医疗保健咨询公司工作，并从事外汇交易业务。他拥有伊丽莎白镇学院的国际商务学士学位和法国南锡国际管理学院的国际管理学士学位。
Justin Schreiber was appointed President and CEO of Immudyne, Inc. upon the closing of the sale of the legacy beta glucan business in February 2018. Mr. Schreiber was appointed as Immudyne PR's President on April 1 2017. Mr. Schreiber is the President and founder of JLS Ventures, an investment and capital markets advisory firm that invests in and consults with emerging growth publicly-traded companies. Prior to founding JLS Ventures, Mr. Schreiber ran a consulting business that provided investor relations, advisory services and capital raising solutions to small publicly traded companies. In addition to his capital markets experience, Mr. Schreiber previously worked for a global healthcare consulting firm as well as in the foreign currency trading business. He holds a BS in International Business from Elizabethtown College and a BA in International Management from the ICN école de management in Nancy, France. - Justin Schreiber是风险投资和资本市场咨询公司JLS Ventures的总裁兼创始人，该公司与企业家和新兴成长型公司合作，在技术，医疗保健和消费产品垂直领域开发颠覆性产品和技术。自2018年2月以来，Schreiber先生一直担任Conversion Labs Inc.的总裁，首席执行官兼董事，该公司是一家直接面向消费者的远程医疗公司。在创立JLS Ventures之前，Schreiber先生经营一家咨询业务，为小型上市公司提供投资者关系，咨询服务和融资解决方案。除了资本市场经验，Schreiber先生此前曾在一家全球医疗保健咨询公司工作，并从事外汇交易业务。他拥有伊丽莎白镇学院的国际商务学士学位和法国南锡国际管理学院的国际管理学士学位。
- Justin Schreiber was appointed President and CEO of Immudyne, Inc. upon the closing of the sale of the legacy beta glucan business in February 2018. Mr. Schreiber was appointed as Immudyne PR's President on April 1 2017. Mr. Schreiber is the President and founder of JLS Ventures, an investment and capital markets advisory firm that invests in and consults with emerging growth publicly-traded companies. Prior to founding JLS Ventures, Mr. Schreiber ran a consulting business that provided investor relations, advisory services and capital raising solutions to small publicly traded companies. In addition to his capital markets experience, Mr. Schreiber previously worked for a global healthcare consulting firm as well as in the foreign currency trading business. He holds a BS in International Business from Elizabethtown College and a BA in International Management from the ICN école de management in Nancy, France.
- John R. Strawn, Jr.
-
John R.Strawn，Jr.自2011年7月起担任公司董事会成员。Strawn先生为董事会带来了超过25年的法律经验，包括我们知识产权投资组合的丰富知识。他的业务专注于复杂的商业诉讼。Strawn先生成功地代表公司工作了10多年，包括在多项专利的所有权和许可纠纷中。在2009年的一场上诉维持原判的陪审团审判中获胜后，这件事以对公司有利的条件得到了解决。2010年，Strawn先生成为德克萨斯州休斯敦Strawn Pickens LLP的创始合伙人。在创立Strawn Pickens之前，Strawn先生自1992年以来是Cruse Scott Henderson&Allen LLP的联合管理合伙人，这是一家位于德克萨斯州休斯敦的律师事务所。Strawn先生在德克萨斯大学法学院获得法学博士学位，并在达特茅斯学院获得学士学位。
John R. Strawn, Jr. has served as a member of Board of Directors since July 2011. His practice focuses on complex commercial litigation. Mr. Strawn has successfully represented the company for over 10 years, including in a dispute over the ownership and licensing of multiple patents. After prevailing in a jury trial that was upheld on appeal in 2009 the matter was settled on favorable terms for the company. In 2010 Mr. Strawn became a founding partner of Strawn Pickens LLP in Houston, Texas. Prior to founding Strawn Pickens, Mr. Strawn was the Co-Managing Partner of Cruse Scott Henderson & Allen LLP, a law firm based in Houston, Texas, since 1992. Mr. Strawn received his Juris Doctor from the University of Texas Law School and his bachelor's degree from Dartmouth College. - John R.Strawn，Jr.自2011年7月起担任公司董事会成员。Strawn先生为董事会带来了超过25年的法律经验，包括我们知识产权投资组合的丰富知识。他的业务专注于复杂的商业诉讼。Strawn先生成功地代表公司工作了10多年，包括在多项专利的所有权和许可纠纷中。在2009年的一场上诉维持原判的陪审团审判中获胜后，这件事以对公司有利的条件得到了解决。2010年，Strawn先生成为德克萨斯州休斯敦Strawn Pickens LLP的创始合伙人。在创立Strawn Pickens之前，Strawn先生自1992年以来是Cruse Scott Henderson&Allen LLP的联合管理合伙人，这是一家位于德克萨斯州休斯敦的律师事务所。Strawn先生在德克萨斯大学法学院获得法学博士学位，并在达特茅斯学院获得学士学位。
- John R. Strawn, Jr. has served as a member of Board of Directors since July 2011. His practice focuses on complex commercial litigation. Mr. Strawn has successfully represented the company for over 10 years, including in a dispute over the ownership and licensing of multiple patents. After prevailing in a jury trial that was upheld on appeal in 2009 the matter was settled on favorable terms for the company. In 2010 Mr. Strawn became a founding partner of Strawn Pickens LLP in Houston, Texas. Prior to founding Strawn Pickens, Mr. Strawn was the Co-Managing Partner of Cruse Scott Henderson & Allen LLP, a law firm based in Houston, Texas, since 1992. Mr. Strawn received his Juris Doctor from the University of Texas Law School and his bachelor's degree from Dartmouth College.
- Joseph V. DiTrolio
-
Joseph V.Ditrolio于2014年9月4日被任命为我们的董事会成员。根据2012年的咨询协议，Ditrolio博士自2013年5月29日起担任Immudyne，Inc.的美国首席医疗官。Ditrolio博士担任OneMedPlace的顾问和Urovalve Inc.的顾问。Ditrolio博士是全世界公认的发明家，研究员和讲师，并且是UMDNJ泌尿科的临床教授。他是多项专利的持有者，也是新泽西医学院泌尿外科的临床教授，以及圣巴纳巴斯医学中心医疗保健系统泌尿外科的最近的主席。他毕业于里士满大学、巴黎大学、索邦大学和新泽西医学院。他是美国泌尿外科委员会的文凭，在泌尿外科社区因创新技术和产品开发而备受尊敬。
Joseph V. DiTrolio was appointed to Board of Directors on September 4 2014. Dr. DiTrolio has been the Chief Medical Officer of United States at ImmuDyne, Inc. since May 29 2013 pursuant to a 2012 consulting agreement. Dr. DiTrolio serves as an advisor of OneMedPlace and as an advisor of Urovalve Inc. Dr. DiTrolio is recognized world-wide as an inventor, researcher and lecturer and is a Clinical Professor of Urology, UMDNJ. He is the holder of several patents and is Clinical Professor of Surgery, Division of Urology at New Jersey Medical School, and the recent Chairman of the Department of Urology for the St. Barnabas Medical Center Healthcare System. He is a graduate of the University of Richmond, University of Paris, Sorbonne and New Jersey Medical School. He is a Diplomate of the American Board of Urology and is well respected in the urology community for innovative techniques and product development. - Joseph V.Ditrolio于2014年9月4日被任命为我们的董事会成员。根据2012年的咨询协议，Ditrolio博士自2013年5月29日起担任Immudyne，Inc.的美国首席医疗官。Ditrolio博士担任OneMedPlace的顾问和Urovalve Inc.的顾问。Ditrolio博士是全世界公认的发明家，研究员和讲师，并且是UMDNJ泌尿科的临床教授。他是多项专利的持有者，也是新泽西医学院泌尿外科的临床教授，以及圣巴纳巴斯医学中心医疗保健系统泌尿外科的最近的主席。他毕业于里士满大学、巴黎大学、索邦大学和新泽西医学院。他是美国泌尿外科委员会的文凭，在泌尿外科社区因创新技术和产品开发而备受尊敬。
- Joseph V. DiTrolio was appointed to Board of Directors on September 4 2014. Dr. DiTrolio has been the Chief Medical Officer of United States at ImmuDyne, Inc. since May 29 2013 pursuant to a 2012 consulting agreement. Dr. DiTrolio serves as an advisor of OneMedPlace and as an advisor of Urovalve Inc. Dr. DiTrolio is recognized world-wide as an inventor, researcher and lecturer and is a Clinical Professor of Urology, UMDNJ. He is the holder of several patents and is Clinical Professor of Surgery, Division of Urology at New Jersey Medical School, and the recent Chairman of the Department of Urology for the St. Barnabas Medical Center Healthcare System. He is a graduate of the University of Richmond, University of Paris, Sorbonne and New Jersey Medical School. He is a Diplomate of the American Board of Urology and is well respected in the urology community for innovative techniques and product development.
- William J. Febbo
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Calum MacRae
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Joan LaRovere
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
高管简历
中英对照 | 中文 | 英文- Justin Schreiber
Justin Schreiber是风险投资和资本市场咨询公司JLS Ventures的总裁兼创始人，该公司与企业家和新兴成长型公司合作，在技术，医疗保健和消费产品垂直领域开发颠覆性产品和技术。自2018年2月以来，Schreiber先生一直担任Conversion Labs Inc.的总裁，首席执行官兼董事，该公司是一家直接面向消费者的远程医疗公司。在创立JLS Ventures之前，Schreiber先生经营一家咨询业务，为小型上市公司提供投资者关系，咨询服务和融资解决方案。除了资本市场经验，Schreiber先生此前曾在一家全球医疗保健咨询公司工作，并从事外汇交易业务。他拥有伊丽莎白镇学院的国际商务学士学位和法国南锡国际管理学院的国际管理学士学位。
Justin Schreiber was appointed President and CEO of Immudyne, Inc. upon the closing of the sale of the legacy beta glucan business in February 2018. Mr. Schreiber was appointed as Immudyne PR's President on April 1 2017. Mr. Schreiber is the President and founder of JLS Ventures, an investment and capital markets advisory firm that invests in and consults with emerging growth publicly-traded companies. Prior to founding JLS Ventures, Mr. Schreiber ran a consulting business that provided investor relations, advisory services and capital raising solutions to small publicly traded companies. In addition to his capital markets experience, Mr. Schreiber previously worked for a global healthcare consulting firm as well as in the foreign currency trading business. He holds a BS in International Business from Elizabethtown College and a BA in International Management from the ICN école de management in Nancy, France.- Justin Schreiber是风险投资和资本市场咨询公司JLS Ventures的总裁兼创始人，该公司与企业家和新兴成长型公司合作，在技术，医疗保健和消费产品垂直领域开发颠覆性产品和技术。自2018年2月以来，Schreiber先生一直担任Conversion Labs Inc.的总裁，首席执行官兼董事，该公司是一家直接面向消费者的远程医疗公司。在创立JLS Ventures之前，Schreiber先生经营一家咨询业务，为小型上市公司提供投资者关系，咨询服务和融资解决方案。除了资本市场经验，Schreiber先生此前曾在一家全球医疗保健咨询公司工作，并从事外汇交易业务。他拥有伊丽莎白镇学院的国际商务学士学位和法国南锡国际管理学院的国际管理学士学位。
- Justin Schreiber was appointed President and CEO of Immudyne, Inc. upon the closing of the sale of the legacy beta glucan business in February 2018. Mr. Schreiber was appointed as Immudyne PR's President on April 1 2017. Mr. Schreiber is the President and founder of JLS Ventures, an investment and capital markets advisory firm that invests in and consults with emerging growth publicly-traded companies. Prior to founding JLS Ventures, Mr. Schreiber ran a consulting business that provided investor relations, advisory services and capital raising solutions to small publicly traded companies. In addition to his capital markets experience, Mr. Schreiber previously worked for a global healthcare consulting firm as well as in the foreign currency trading business. He holds a BS in International Business from Elizabethtown College and a BA in International Management from the ICN école de management in Nancy, France.
- Stefan Galluppi
Stefan Galluppi是Immudyne PR的首席执行官和Immudyne的首席运营官。Stefan Galluppi是Immudyne PR的首席执行官和Immudyne的首席运营官。Galluppi先生于2018年2月在出售传统β葡聚糖业务后辞去Immudyne，Inc.的董事职务，但在Aldridge先生于2018年5月31日辞职后再次被任命。Galluppi先生结合了10多年在构建技术平台以直接面向消费者的营销活动方面的经验。此前，他曾担任Runaway Products公司（DRTV驱动的营销公司）的首席技术官，该公司的核心专注于构建和优化系统，以实现最大的效率和盈利能力。
Stefan Galluppi was the Chief Executive Officer of Immudyne PR and the Chief Operating Officer of Immudyne. Stefan Galluppi is the Chief Executive Officer of Immudyne PR and the Chief Operating Officer of Immudyne. Mr. Galluppi resigned as a Director of Immudyne, Inc. in February 2018 upon the sale of the legacy beta glucan business but was re-appointed after the resignation of Mr. Aldridge on May 31 2018. Mr. Galluppi combines over 10 years of experience in building technology platforms for direct to consumer marketing campaigns. Previously, he served as the CTO of Runaway Products, a DRTV driven marketing firm with a core focus on building and optimizing systems to scale campaigns for maximum efficiency and profitability.- Stefan Galluppi是Immudyne PR的首席执行官和Immudyne的首席运营官。Stefan Galluppi是Immudyne PR的首席执行官和Immudyne的首席运营官。Galluppi先生于2018年2月在出售传统β葡聚糖业务后辞去Immudyne，Inc.的董事职务，但在Aldridge先生于2018年5月31日辞职后再次被任命。Galluppi先生结合了10多年在构建技术平台以直接面向消费者的营销活动方面的经验。此前，他曾担任Runaway Products公司（DRTV驱动的营销公司）的首席技术官，该公司的核心专注于构建和优化系统，以实现最大的效率和盈利能力。
- Stefan Galluppi was the Chief Executive Officer of Immudyne PR and the Chief Operating Officer of Immudyne. Stefan Galluppi is the Chief Executive Officer of Immudyne PR and the Chief Operating Officer of Immudyne. Mr. Galluppi resigned as a Director of Immudyne, Inc. in February 2018 upon the sale of the legacy beta glucan business but was re-appointed after the resignation of Mr. Aldridge on May 31 2018. Mr. Galluppi combines over 10 years of experience in building technology platforms for direct to consumer marketing campaigns. Previously, he served as the CTO of Runaway Products, a DRTV driven marketing firm with a core focus on building and optimizing systems to scale campaigns for maximum efficiency and profitability.
- Marc Benathen
Marc Benathen拥有超过18年的金融，运营和消费产品/服务高级管理经验。此前，他曾参与消费、技术和媒体行业的6家公司，担任首席财务官、副总裁和董事。从2017年到2021年1月，Benathen先生担任Blink Holdings，Inc.DBA Blink Fitness（一家全民健身公司）的首席财务官。从2014年到2017年，他担任Blink Fitness的财务副总裁。从2010年12月到2014年1月，他曾担任Ann，Inc.（纽约证券交易所上市的零售公司，专注于女性时尚）的公司财务高级经理。Benathen先生目前也是巴鲁克学院校友会的董事和巴鲁克学院基金（巴鲁克学院的慈善和校友机构）的前任受托人。他以优异的成绩获得了巴鲁克学院的本科学位。
Marc Benathen combines over 18 years of experience in financial, operational and consumer products/services senior management. Previously, he had been involved in 6 companies in the consumer, technology and media industries holding positions including Chief Financial Officer, Vice President and Director. From 2017 through January 2021 Mr. Benathen was the Chief Financial Officer for Blink Holdings, Inc. dba Blink Fitness, a national fitness company. From 2014 to 2017 he was Vice President of Finance for Blink Fitness. From December 2010 to January 2014 he was Senior Manager of Corporate Finance of ANN, Inc., a NYSE-listed retail company that focused on women's fashion. Mr. Benathen is also currently a director of Baruch College Alumni Association and past Trustee of the Baruch College Fund, a charitable and alumni arm of Baruch College. He has an undergraduate degree from Baruch College with Honors.- Marc Benathen拥有超过18年的金融，运营和消费产品/服务高级管理经验。此前，他曾参与消费、技术和媒体行业的6家公司，担任首席财务官、副总裁和董事。从2017年到2021年1月，Benathen先生担任Blink Holdings，Inc.DBA Blink Fitness（一家全民健身公司）的首席财务官。从2014年到2017年，他担任Blink Fitness的财务副总裁。从2010年12月到2014年1月，他曾担任Ann，Inc.（纽约证券交易所上市的零售公司，专注于女性时尚）的公司财务高级经理。Benathen先生目前也是巴鲁克学院校友会的董事和巴鲁克学院基金（巴鲁克学院的慈善和校友机构）的前任受托人。他以优异的成绩获得了巴鲁克学院的本科学位。
- Marc Benathen combines over 18 years of experience in financial, operational and consumer products/services senior management. Previously, he had been involved in 6 companies in the consumer, technology and media industries holding positions including Chief Financial Officer, Vice President and Director. From 2017 through January 2021 Mr. Benathen was the Chief Financial Officer for Blink Holdings, Inc. dba Blink Fitness, a national fitness company. From 2014 to 2017 he was Vice President of Finance for Blink Fitness. From December 2010 to January 2014 he was Senior Manager of Corporate Finance of ANN, Inc., a NYSE-listed retail company that focused on women's fashion. Mr. Benathen is also currently a director of Baruch College Alumni Association and past Trustee of the Baruch College Fund, a charitable and alumni arm of Baruch College. He has an undergraduate degree from Baruch College with Honors.
- Nicholas Alvarez
Nicholas Alvarez被任命为首席收购官。27岁的Alvarez先生是数字营销领域的一位出色的高管。他负责监督公司的客户获取工作，包括所有品牌的媒体购买和广告策略，不包括PDFSimpri。任职公司之前，他曾任职Cheviot Capital公司和Internet Brands公司，管理超过1亿美元的付费媒体预算。从2015年到2016年，他是互联网品牌的数字营销专家，并在Lawyers.com，CarsDirect.com等网站工作。从2016年至2018年，他担任Cheviot Capital的首席媒体采购员，从2018年至今，他一直担任LifeMD的客户获取主管。他拥有Loyola Marymount大学的本科学位。
Nicholas Alvarez was appointed as Chief Acquisition Officer. Mr. Alvarez is an accomplished executive in the digital marketing space. He is responsible for overseeing the Company's customer acquisition efforts including media buying and advertising strategy across all brands, excluding PDFSimpli. Prior to his work for the Company, he worked at agencies Cheviot Capital and Internet Brands, managing over $100 million in paid media budgets. From 2015-2016 he was a digital marketing specialist for Internet Brands and worked on sites such as Lawyers.com, Carsdirect.com, among others. From 2016-2018 he worked as a Head Media Buyer at Cheviot Capital, and from 2018 to the present has served as Head of Customer Acquisition at LifeMD. He has an undergraduate degree from Loyola Marymount University.- Nicholas Alvarez被任命为首席收购官。27岁的Alvarez先生是数字营销领域的一位出色的高管。他负责监督公司的客户获取工作，包括所有品牌的媒体购买和广告策略，不包括PDFSimpri。任职公司之前，他曾任职Cheviot Capital公司和Internet Brands公司，管理超过1亿美元的付费媒体预算。从2015年到2016年，他是互联网品牌的数字营销专家，并在Lawyers.com，CarsDirect.com等网站工作。从2016年至2018年，他担任Cheviot Capital的首席媒体采购员，从2018年至今，他一直担任LifeMD的客户获取主管。他拥有Loyola Marymount大学的本科学位。
- Nicholas Alvarez was appointed as Chief Acquisition Officer. Mr. Alvarez is an accomplished executive in the digital marketing space. He is responsible for overseeing the Company's customer acquisition efforts including media buying and advertising strategy across all brands, excluding PDFSimpli. Prior to his work for the Company, he worked at agencies Cheviot Capital and Internet Brands, managing over $100 million in paid media budgets. From 2015-2016 he was a digital marketing specialist for Internet Brands and worked on sites such as Lawyers.com, Carsdirect.com, among others. From 2016-2018 he worked as a Head Media Buyer at Cheviot Capital, and from 2018 to the present has served as Head of Customer Acquisition at LifeMD. He has an undergraduate degree from Loyola Marymount University.
- Eric Yecies
Eric Yecies在生命科学领域拥有超过16年的法律实践经验。此前，他曾参与三个法律行业的律师事务所，担任包括助理、高级助理、高级法律顾问和合伙人。从2013年到2020年，Yecies先生担任全球律师事务所Holland&Knight知识产权集团的高级法律顾问兼合伙人。从2008年到2013年，他曾担任Goodwin Procter公司（全球律师事务所）的专利诉讼集团的高级合伙人。从2004年到2008年，他曾担任Ropes&Gray公司（全球律师事务所）的Fish and Neave知识产权集团的合伙人。他拥有宾夕法尼亚大学的生物分子浓度学士学位和硕士学位，以及纽约大学法学院的法学博士学位。
Eric Yecies combines over 16 years of experience practicing law in the life sciences space. Previously, he had been involved in three law firms in the legal industry, holding positions including, Associate, Senior Associate, Senior Counsel, and Partner. From 2013 to 2020 Mr. Yecies was a Senior Counsel and then Partner in the Intellectual Property Group of Holland & Knight, a global law firm. From 2008 to 2013 he was a Senior Associate in the Patent Litigation Group of Goodwin Procter LLP, a global law firm. From 2004 to 2008 he was an Associate in the Fish and Neave Intellectual Property Group of Ropes & Gray LLP, a global law firm. He has an undergraduate degree and master's degree in biology molecular concentrations from the University of Pennsylvania and a JD from New York University School of Law.- Eric Yecies在生命科学领域拥有超过16年的法律实践经验。此前，他曾参与三个法律行业的律师事务所，担任包括助理、高级助理、高级法律顾问和合伙人。从2013年到2020年，Yecies先生担任全球律师事务所Holland&Knight知识产权集团的高级法律顾问兼合伙人。从2008年到2013年，他曾担任Goodwin Procter公司（全球律师事务所）的专利诉讼集团的高级合伙人。从2004年到2008年，他曾担任Ropes&Gray公司（全球律师事务所）的Fish and Neave知识产权集团的合伙人。他拥有宾夕法尼亚大学的生物分子浓度学士学位和硕士学位，以及纽约大学法学院的法学博士学位。
- Eric Yecies combines over 16 years of experience practicing law in the life sciences space. Previously, he had been involved in three law firms in the legal industry, holding positions including, Associate, Senior Associate, Senior Counsel, and Partner. From 2013 to 2020 Mr. Yecies was a Senior Counsel and then Partner in the Intellectual Property Group of Holland & Knight, a global law firm. From 2008 to 2013 he was a Senior Associate in the Patent Litigation Group of Goodwin Procter LLP, a global law firm. From 2004 to 2008 he was an Associate in the Fish and Neave Intellectual Property Group of Ropes & Gray LLP, a global law firm. He has an undergraduate degree and master's degree in biology molecular concentrations from the University of Pennsylvania and a JD from New York University School of Law.
- Shayna Webb Dray
Shayna Webb Dray，2023年9月至2025年7月担任公司运营高级副总裁。在这个角色中，她负责启动和随后扩展公司的体重管理计划，并监督护理中心、药房、临床运营和项目管理办公室的日常管理。Webb Dray女士此前曾于2021年5月至2023年9月担任公司供应链与采购主管，在那里她带头创建了全面的供应链战略。在此之前，作为格雷厄姆控股公司旗下Kaplan Publishing的运营执行总监，从2016年3月到2021年5月，她通过供应链优化每年节省大量资金，并就关键的运营和战略举措提供建议。Webb Dray拥有雪城大学供应链管理和市场营销理学学士学位，她曾是该大学的Brethen学者。
Shayna Webb Dray,served as the Senior Vice President of Operations of the Company from September 2023 to July 2025. In this role, she was responsible for the launch and subsequent scaling of the Company's weight management program, as well as overseeing day-to-day management of the Care Center, Pharmacy, Clinical Operations, and the Project Management Office. Ms. Webb Dray previously served as the Head of Supply Chain & Procurement of the Company from May 2021 to September 2023, where she spearheaded the creation of a comprehensive supply chain strategy. Before that, as the Executive Director of Operations at Kaplan Publishing, a subsidiary of Graham Holdings Company, from March 2016 to May 2021, she generated substantial annual savings through supply chain optimization and advised on key operational and strategic initiatives.Ms. Webb Dray holds a Bachelor of Science in Supply Chain Management and Marketing from Syracuse University, where she was a Brethen Scholar.- Shayna Webb Dray，2023年9月至2025年7月担任公司运营高级副总裁。在这个角色中，她负责启动和随后扩展公司的体重管理计划，并监督护理中心、药房、临床运营和项目管理办公室的日常管理。Webb Dray女士此前曾于2021年5月至2023年9月担任公司供应链与采购主管，在那里她带头创建了全面的供应链战略。在此之前，作为格雷厄姆控股公司旗下Kaplan Publishing的运营执行总监，从2016年3月到2021年5月，她通过供应链优化每年节省大量资金，并就关键的运营和战略举措提供建议。Webb Dray拥有雪城大学供应链管理和市场营销理学学士学位，她曾是该大学的Brethen学者。
- Shayna Webb Dray,served as the Senior Vice President of Operations of the Company from September 2023 to July 2025. In this role, she was responsible for the launch and subsequent scaling of the Company's weight management program, as well as overseeing day-to-day management of the Care Center, Pharmacy, Clinical Operations, and the Project Management Office. Ms. Webb Dray previously served as the Head of Supply Chain & Procurement of the Company from May 2021 to September 2023, where she spearheaded the creation of a comprehensive supply chain strategy. Before that, as the Executive Director of Operations at Kaplan Publishing, a subsidiary of Graham Holdings Company, from March 2016 to May 2021, she generated substantial annual savings through supply chain optimization and advised on key operational and strategic initiatives.Ms. Webb Dray holds a Bachelor of Science in Supply Chain Management and Marketing from Syracuse University, where she was a Brethen Scholar.
- Maria Stan
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Jessica Friedeman
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Shane Biffar
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Dennis Wijnker
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介